MiR21 sensitized B-lymphoma cells to ABT-199 via ICOS/ICOSL-mediated interaction of Treg cells with endothelial cells

Table 1 Clinical characteristics of patients with DLBCL (n = 203)

	High miR21	Low miR21	P-value
Age
> 60 years	35	39	0.523
≤ 60 years	67	62	0.523
Sex
Female	39	41	0.731
Male	63	60	0.731
Ann Arbor stage
I to II	50	65	0.027
III to IV	52	36	0.027
Extranodal involvement
No	18	17
Yes	84	84	0.882
Serum LDH level
Normal	53	68	0.071
Abnormal	49	33	0.071
IPI score
Low and intermediate-low risk	59	75	0.013
Intermediate-high and high risk	43	26	0.013

ISSN: 1756-9966